Date: 16 November 2017
Time: 17:30 - 20:00
Venue: MedImmune, Granta Park, Great Abingdon, Cambridge CB21 6GH
Hosted by AstraZeneca at their MedImmune site, this meeting will feature speakers from the University of Cambridge/ Wellcome Trust Sanger Institute and CN Bio Innovations as well as AstraZeneca. 
Cambridge New Therapeutics Forum events are open to all scientists reseraching new therapeutics in Cambridge and the local area.
Programme
17.30 - Doors open
18.00 - Welcome from the Hosts
Mark Fidock, VP and Head, Personalised Healthcare and Biomarker Laboratories, AstraZeneca
18.10 - Human Pluripotent Stem Cells to Model and to Study Liver Disease
Prof Ludovic Vallier, University of Cambridge/ Wellcome Trust Sanger Institute
18.40 - Microphysiological Systems for Drug Discovery
David Hughes, Chief Technical Officer, CN Bio Innovations
18.55 - Microphysiological Systems: Their Development and Application in the Pharmaceutical Industry
Rhiannon David, Senior Scientist, Drug Safety and Metabolism, AstraZeneca
19.10 - Networking and Refreshments
20.00 - Close
Click here to book your place
